Details about James Mason

Access statistics for papers by James Mason.

Last updated 2023-04-09. Update your information in the RePEc Author Service.

Short-id: pma2333

Working Papers

2002

1. Optometrist prescribing of therapeutic agents: economic implications for the UK
   Working Papers, Centre for Health Economics, University of York View citations (1)
2. Topical preparations for the treatment of psoriasis in primary care: a systematic review
   Working Papers, Centre for Health Economics, University of York

1999

3. Evaluating change in professional behaviour: issues in design and analysis
   Working Papers, Centre for Health Economics, University of York

1998

4. NICEly does it: economic analysis within evidence-based clinical practice guidelines
   Working Papers, Centre for Health Economics, University of York

1995

5. Screening for diabetic retinopathy by optometrists: effectiveness and cost-effectiveness
   Working Papers, Centre for Health Economics, University of York
6. The DH register of cost-effectiveness studies: a review of study content and quality
   Working Papers, Centre for Health Economics, University of York View citations (2)

Journal Articles

2022

1. The urgent case for stronger climate targets for international shipping
   Climate Policy, 2022, 22, (3), 301-309 View citations (2)

2021

2. Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data
   Medical Decision Making, 2021, 41, (6), 667-684

2019

3. Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
   PharmacoEconomics, 2019, 37, (6), 869-869

2018

4. Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
   PharmacoEconomics, 2018, 36, (4), 399-406

2017

5. Agreement between gastrointestinal panel testing and standard microbiology methods for detecting pathogens in suspected infectious gastroenteritis: Test evaluation and meta-analysis in the absence of a reference standard
   PLOS ONE, 2017, 12, (3), 1-16
6. Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature Review
   PharmacoEconomics, 2017, 35, (5), 501-515 View citations (1)

2014

7. Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials
   PLOS ONE, 2014, 9, (2), 1-7

2013

8. Compassionate containment? Balancing technical safety and therapy in the design of psychiatric wards
   Social Science & Medicine, 2013, 97, (C), 201-209 View citations (7)
9. Creating ‘therapeutic landscapes’ for mental health carers in inpatient settings: A dynamic perspective on permeability and inclusivity
   Social Science & Medicine, 2013, 91, (C), 122-129 View citations (6)
10. Spaces for smoking in a psychiatric hospital: Social capital, resistance to control, and significance for ‘therapeutic landscapes’
    Social Science & Medicine, 2013, 97, (C), 104-111 View citations (4)

2002

11. Optometrist prescribing of therapeutic agents: findings of the AESOP survey
    Health Policy, 2002, 60, (2), 185-197

2000

12. The Importance of Achieving Additional Drug Benefits at a Reasonable Cost
    PharmacoEconomics, 2000, 17, (4), 319-324

1999

13. A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines
    Health Policy, 1999, 47, (1), 37-52 View citations (3)

1997

14. Biotechnology: a special case for health technology assessment?
    Health Policy, 1997, 41, (1), 73-81 View citations (2)

1996

15. Student corner
    Health Economics, 1996, 5, (4), 375-379

1995

16. Cost-effectiveness league tables: think of the fans
    Health Policy, 1995, 31, (3), 231-238 View citations (6)
17. Reporting guidelines for economic studies
    Health Economics, 1995, 4, (2), 85-94 View citations (10)

1993

18. Cost-effectiveness league tables: More harm than good?
    Social Science & Medicine, 1993, 37, (1), 33-40 View citations (21)